PURE PURE BIOSCIENCE, INC.
Miscellaneous Chemical Products · OTC · SEC CIK 1006028 · Fiscal year ends 07/31
Financial factors as of 2026-07-31 (2026Q4), TTM = sum of the last four quarters
Growth
TTM revenue YoY5.3%
TTM net income YoY-3.5%
TTM EPS YoY0.0%
Revenue 3-yr CAGR7.4%
Net income 3-yr CAGR—
Margins
Gross margin57.3%
Operating margin-90.0%
Net margin-107.3%
FCF margin—
EBITDA margin-89.8%
Returns
ROE—
ROA-220.6%
ROIC (approx.)—
Asset turnover2.06x
Leverage & solvency
Liabilities / assets636.4%
Debt / equity—
Current ratio0.27x
Interest coverage-5.12x
Cash quality & payout
Operating cash flow / net income0.70x
Accruals ratio-66.2%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20262026-07-31 | FY20252025-07-31 |
|---|---|---|
| Income statement | ||
| Revenue | $2.31M | $2.20M |
| Cost of revenue | $992,000 | $899,000 |
| Gross profit | $1.33M | $1.30M |
| R&D expense | $332,000 | $316,000 |
| SG&A expense | $3.08M | $3.26M |
| Operating income | -$2.08M | -$2.27M |
| Interest expense | $407,000 | $299,000 |
| Income tax | $0 | $0 |
| Net income | -$2.48M | -$2.40M |
| EBITDA | -$2.08M | -$2.27M |
| EPS (basic) | -0.02 | -0.02 |
| EPS (diluted) | -0.02 | -0.02 |
| Weighted avg. shares (diluted) | 116.46M | 111.86M |
| Balance sheet | ||
| Cash & equivalents | $569,000 | $334,000 |
| Receivables | $334,000 | $474,000 |
| Inventory | $193,000 | $141,000 |
| Current assets | $1.19M | $1.05M |
| PP&E, net | $8,000 | $11,000 |
| Total assets | $1.19M | $1.06M |
| Current liabilities | $4.37M | $2.11M |
| Long-term debt | $6.60M | — |
| Total debt | $6.60M | — |
| Total liabilities | $7.59M | $6.17M |
| Shareholders' equity | -$6.40M | -$5.12M |
| Net debt | $6.03M | — |
| Shares outstanding | 130.02M | 111.89M |
| Cash flow statement | ||
| Operating cash flow | -$1.74M | -$2.02M |
| Financing cash flow | $1.97M | $2.00M |
| Depreciation & amortization | $3,000 | $2,000 |
| Stock-based compensation | $197,000 | $147,000 |
Free plan shows the latest 2 periods; Pro shows all 16 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.